We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$8.4B
AUM Growth
+$1.66B
Cap. Flow
+$1.33B
Cap. Flow %
15.85%
Top 10 Hldgs %
61.33%
Holding
510
New
182
Increased
113
Reduced
52
Closed
146

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$79.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$74.4M
3
KVUE icon
Kenvue
KVUE
+$65.3M
4
ELF icon
e.l.f. Beauty
ELF
+$51.7M
5
GSK icon
GSK
GSK
+$46.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$96.3M
2
EXAS
Exact Sciences
EXAS
+$56.4M
3
PTCT icon
PTC Therapeutics
PTCT
+$34.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$28M
5
MDB icon
MongoDB
MDB
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 32.56%
2 Technology 5.44%
3 Consumer Discretionary 5.13%
4 Consumer Staples 2.69%
5 Communication Services 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DGX icon
326
Quest Diagnostics
DGX
$26.3B
$234K ﹤0.01%
+1,351
New +$246K
PWCM
327
PowerCompute, Inc. Common Stock
PWCM
$1.37M
$234K ﹤0.01%
21,104
+6,086
+41% +$146K
SWX icon
328
Southwest Gas
SWX
$6.68B
$233K ﹤0.01%
+2,918
New +$234K
NRG icon
329
NRG Energy
NRG
$25.4B
$233K ﹤0.01%
1,461
-191
-12% -$31.6K
ALL icon
330
Allstate
ALL
$68B
$232K ﹤0.01%
+1,116
New +$228K
LH icon
331
Labcorp
LH
$25.9B
$229K ﹤0.01%
+911
New +$242K
BDRX
332
Biodexa Pharmaceuticals
BDRX
$1.54M
$227K ﹤0.01%
+20,000
New +$569K
GM icon
333
General Motors
GM
$76.7B
$226K ﹤0.01%
+2,776
New +$196K
STLA icon
334
Stellantis
STLA
$20.8B
$219K ﹤0.01%
20,150
+7,166
+55% +$77.1K
GLW icon
335
Corning
GLW
$143B
$219K ﹤0.01%
+2,505
New +$216K
EVRG icon
336
Evergy
EVRG
$19.3B
$219K ﹤0.01%
+3,019
New +$229K
KKR icon
337
KKR & Co
KKR
$92.8B
$218K ﹤0.01%
1,713
-552
-24% -$68.7K
CPB icon
338
Campbell Soup
CPB
$6.91B
$211K ﹤0.01%
+7,586
New +$228K
SPG icon
339
Simon Property Group
SPG
$71.9B
$211K ﹤0.01%
+1,139
New +$207K
KRE icon
340
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
$210K ﹤0.01%
+3,238
New +$203K
KMX icon
341
CarMax
KMX
$8.29B
$208K ﹤0.01%
+5,376
New +$215K
BRO icon
342
Brown & Brown
BRO
$23.9B
$206K ﹤0.01%
+2,590
New +$216K
BEATW icon
343
Heartbeam Inc Warrant
BEATW
$160K ﹤0.01%
500,000
– –
IVF
344
INVO Fertility Inc
IVF
$1.89M
$156K ﹤0.01%
+41,529
New +$724K
MTEKW icon
345
Maris-Tech Ltd Warrants
MTEKW
$151K ﹤0.01%
1,261,058
– –
BKD icon
346
Brookdale Senior Living
BKD
$3.42B
$151K ﹤0.01%
+13,977
New +$137K
CGAU
347
Centerra Gold
CGAU
$4.13B
$148K ﹤0.01%
+10,301
New +$129K
EXK
348
Endeavour Silver
EXK
$2.77B
$144K ﹤0.01%
+15,288
New +$130K
EDBL
349
Edible Garden
EDBL
$1.2M
$135K ﹤0.01%
+493
New +$317K
GT icon
350
Goodyear
GT
$1.87B
$133K ﹤0.01%
+15,133
New +$119K
12 13
14
15 16

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Armistice Capital held 510 positions worth $8.4B, up 25% from $6.74B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Armistice Capital deployed $1.33B of net new capital in Q4 2025, opening 182 new positions and adding to 113 existing holdings. Its largest new stake was Kenvue: 3,992,196 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $96.3M trimmed.

  • Armistice Capital's largest Q4 2025 buy was Kenvue: 3,992,196 shares worth $68.9M.
  • Armistice Capital added most to Agios Pharmaceuticals in Q4 2025, an estimated $79.7M increase.
  • Armistice Capital's biggest Q4 2025 reduction was Travere Therapeutics, cutting an estimated $96.3M.
  • Armistice Capital fully exited Exact Sciences in Q4 2025, selling an estimated $56.4M.
  • Armistice Capital's ten largest holdings make up 61% of its $8.4B portfolio in Q4 2025.
  • Armistice Capital opened 182 new positions and closed 146 in Q4 2025.
  • Armistice Capital's portfolio value rose 25% quarter-over-quarter to $8.4B.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.